The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
The Histological Features of Chronic Hepatitis C and Autoimmune Chronic Hepatitis: A Comparative Analysis
Open accessAbstract
Before the availability of serological markers for hepatitis C, the morphological features of this diagnosis, which represents most non–A, non–B hepatitis, could not be confirmed. We examined biopsy specimens from 50 patients with chronic hepatitis C and 21 patients with autoimmune chronic hepatitis. Each biopsy specimen was graded on 19 different histological features. The results indicated that at the time of biopsy, the average age of patients with chronic hepatitis C was 46 yr vs. 36 yr for autoimmune chronic hepatitis. Cirrhosis was seen more frequently in autoimmune chronic hepatitis (90%) than in hepatitis C (58%). Features more commonly observed in chronic hepatitis C were bile duct damage (91% vs. 40%), bile duct loss (91% vs. 20%), steatosis (72% vs. 19%) and lymphoid cell aggregation (follicles) within portal tracts (49% vs. 10%). Severe lobular necrosis and inflammation (76% vs. 38%), piecemeal necrosis (81% vs. 10%), multinucleated hepatocytes (29% vs. 6%) and broad areas of parenchymal collapse (76% vs. 6%) were seen more often in autoimmune chronic hepatitis. Exclusion of five patients with autoimmune chronic hepatitis who received immunosuppression before biopsy accentuated these differences. In conclusion, morphological criteria, in addition to serological data, may be useful for differentiating chronic hepatitis C from autoimmune chronic hepatitis, which histologically is a more aggressive disease. (Hepatology 1992;15:572-577).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
Kuo, G., Choo, Q.-L., Alter, H. J., Gitnick, G. L., Redeker, A. G., Purcell, R. H., Miyamura, T., Dienstag, J. L., Alter, M. J., Stevens, C. E., et al. (1989) · Science · doi:10.1126/science.2496467 · Cited by 3,346
HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
Esteban, J. I., Viladomiu, L., Gonzalez, A., Roget, M., Genescà, J., Esteban, R., López-Talavera, J. C., Hernández, J. M., Vargas, V., Buti, M., et al. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90485-6 · Cited by 886
Iversen, L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90876-5 · Cited by 390
Histologic Observations in Human Hepatitis Non–A, Non–B
Dienes, H. P., Popper, H., Arnold, W., & Lobeck, H. (1982) · Hepatology · doi:10.1002/hep.1840020509 · Cited by 192
Baggenstoss, A. H., Soloway, R. D., Summerskill, W. H. J., Elveback, L. R., & Schoenfield, L. J. (1972) · Human Pathology · doi:10.1016/s0046-8177(72)80072-8 · Cited by 183
The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis
Cooksley, W. G. E., Cooksley, E., Bradbear, R. A., Robinson, W., Harrison, M., Halliday, J. W., Powell, L. W., Ng, H.-S., Seah, C. S., Okuda, K., et al. (1986) · Hepatology · doi:10.1002/hep.1840060302 · Cited by 113
The Complex Nature of Mitochondrial Antibodies and Their Relation to Primary Biliary Cirrhosis
Baum, H., & Berg, P. A. (1981) · Seminars in Liver Disease · doi:10.1055/s-2008-1040734 · Cited by 83
A review of lobular, portal, and periportal hepatitis
Ludwig, J. (1977) · Human Pathology · doi:10.1016/s0046-8177(77)80023-3 · Cited by 16
Cited by
An Algorithm for the Grading of Activity in Chronic Hepatitis C
Bedossa, P., & Poynard, T. (1996) · Hepatology · doi:10.1002/hep.510240201 · Cited by 4,088
Bedossa, P. (1994) · Hepatology · doi:10.1002/hep.1840200104 · Cited by 2,003
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,336
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., & Koike, K. (1998) · Nature Medicine · doi:10.1038/2053 · Cited by 1,206
Meeting report: International autoimmune hepatitis group
Johnson, P. J., & McFarlane, I. G. (1993) · Hepatology · doi:10.1002/hep.1840180435 · Cited by 1,090
Adinolfi, L. E., Gambardella, M., Andreana, A., Tripodi, M.-F., Utili, R., & Ruggiero, G. (2001) · Hepatology · doi:10.1053/jhep.2001.24432 · Cited by 1,059
Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and Steatosis
Hourigan, L. F., Macdonald, G. A., Purdie, D., Whitehall, V. H., Shorthouse, C., Clouston, A., & Powell, E. E. (1999) · Hepatology · doi:10.1002/hep.510290401 · Cited by 674
Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.
Moriya, K., Matsuura, Y., Miyamura, T., Koike, K., Shintani, Y., Ishibashi, K., Fujie, H., & Yotsuyanagi, H. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-7-1527 · Cited by 624
Poynard, T., Ratziu, V., McHutchison, J., Manns, M., Goodman, Z., Zeuzem, S., Younossi, Z., & Albrecht, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50267 · Cited by 604
The Long–Term Pathological Evolution of Chronic Hepatitis C
Yano, M., Kumada, H., Kage, M., Ikeda, K., Shimamatsu, K., Inoue, O., Hashimoto, E., Lefkowitch, J. H., Ludwig, J., & Okuda, K. (1996) · Hepatology · doi:10.1002/hep.510230607 · Cited by 598
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3
Rubbia-Brandt, L., Quadri, R., Abid, K., Giostra, E., Malé, P.-J., Mentha, G., Spahr, L., Zarski, J.-P., Borisch, B., Hadengue, A., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80166-x · Cited by 593
AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection
Sheth, S. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00009-9 · Cited by 583
Diagnosis and treatment of autoimmune hepatitis
Czaja, A. J., & Freese, D. K. (2002) · Hepatology · doi:10.1053/jhep.2002.34944 · Cited by 563
Brunt, E. M. (2000) · Hepatology · doi:10.1002/hep.510310136 · Cited by 502
Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease
Lonardo, A., Adinolfi, L. E., Loria, P., Carulli, N., Ruggiero, G., & Day, C. P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.020 · Cited by 477
Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C
Fartoux, L., Poujol-Robert, A., Guéchot, J., Wendum, D., Poupon, R., & Serfaty, L. (2005) · Gut · doi:10.1136/gut.2004.050302 · Cited by 375
Steatosis: Co-factor in Other Liver Diseases *
Powell, E. E., Jonsson, J. R., & Clouston, A. D. (2005) · Hepatology · doi:10.1002/hep.20750 · Cited by 374
Lefkowitch, J. H., Schiff, E. R., Davis, G. L., Perrillo, R. P., Lindsay, K., Bodenheimer, H. C., Balart, L. A., Ortego, T. J., Payne, J., Dienstag, J. L., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90432-c · Cited by 368
Kittlesen, D. J., Chianese-Bullock, K. A., Yao, Z. Q., Braciale, T. J., & Hahn, Y. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10323 · Cited by 333
Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis
Czaja, A. J., & Carpenter, H. A. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)91081-r · Cited by 324
Ohata, K., Hamasaki, K., Toriyama, K., Matsumoto, K., Saeki, A., Yanagi, K., Abiru, S., Nakagawa, Y., Shigeno, M., Miyazoe, S., et al. (2003) · Cancer · doi:10.1002/cncr.11427 · Cited by 322
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation
Schluger, L. K., Sheiner, P. A., Thung, S. N., Lau, J. Y., Min, A., Wolf, D. C., Fiel, I., Zhang, D., Gerber, M. A., Miller, C. M., et al. (1996) · Hepatology · doi:10.1002/hep.510230505 · Cited by 314
Self-citationSerfaty, L., Andreani, T., Giral, P., Carbonell, N., Chazouillères, O., & Poupon, R. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00036-2 · Cited by 299
Castéra, L., Hézode, C., Roudot-Thoraval, F., Bastie, A., Zafrani, E.-S., Pawlotsky, J.-M., & Dhumeaux, D. (2003) · Gut · doi:10.1136/gut.52.2.288 · Cited by 298
Westin, J., Nordlinder, H., Lagging, M., Norkrans, G., & Wejstål, R. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00299-4 · Cited by 280
Lohse, A. W., zum Büschenfelde, K.-H. M., Franz, B., Kanzler, S., Gerken, G., & Dienes, H.-P. (1999) · Hepatology · doi:10.1002/hep.510290409 · Cited by 278
Impact of oestrogens on the progression of liver disease
Shimizu, I. (2003) · Liver International · doi:10.1034/j.1600-0676.2003.00811.x · Cited by 207
Autoimmune hepatitis with incidental histologic features of bile duct injury
Czaja, A. J., & Carpenter, H. A. (2001) · Hepatology · doi:10.1053/jhep.2001.27562 · Cited by 189
“Probable AIH 3 (50)d,i 1 (25) 0 (0)i 4 (20)j 2 (3)d,j”
Pathologic Features and Evolution of Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
Scheuer, P. J. (1998) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)63652-5 · Cited by 106
Autoimmune hepatitis and its variant syndromes
BEN-ARI, Z., & CZAJA, A. J. (2001) · Gut · doi:10.1136/gut.49.4.589 · Cited by 102
Assessment of the histopathological key features in autoimmune hepatitis
de Boer, Y. S., van Nieuwkerk, C. M. J., Witte, B. I., Mulder, C. J. J., Bouma, G., & Bloemena, E. (2015) · Histopathology · doi:10.1111/his.12558 · Cited by 85
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions
Leslie, J., Geh, D., Elsharkawy, A. M., Mann, D. A., & Vacca, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.029 · Cited by 61
Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis
Nezu, S., Tanaka, A., Yasui, H., Imamura, M., Nakajima, H., Ishida, H., & Takahashi, S. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04434.x · Cited by 52
Metadata
- Authors
- Bach, N., Thung, S. N., & Schaffner, F.
- Venue
- Hepatology
- Published
- 1992-04
- Volume
- 15
- Issue
- 4
- Pages
- 572-577
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1976875921
- Cited by
- 500
- References
- 8
- FWCI
- 17.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.